Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 7 de 7
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Biosens Bioelectron ; 223: 115018, 2023 Mar 01.
Article de Anglais | MEDLINE | ID: mdl-36549111

RÉSUMÉ

The conventional heating, ventilation, and air conditioning (HVAC) systems are based on a set-point control approach that only considers the temperature of the environment without reflecting the thermophysiological status of the occupant. This approach not only fails to fully satisfy individual thermal preferences, but it also makes an HVAC operation energy-inefficient. One possible solution is to control the indoor thermal condition based on an accurate prediction of the occupant's thermal comfort to prevent any unnecessary energy consumption. Here, we present an artificial intelligence (AI) wearable sensor-based human-in-the-loop HVAC control system that is operated on a real-time basis reflecting the thermophysiological condition of the occupant to automatically improve their thermal comfort while reducing the energy consumption of the building. The wristband-type, AI-based, three-point wearable temperature sensor offers excellent thermal comfort prediction accuracy (93.9%), enabling a human-centric HVAC control operation. A proof-of-concept demonstration of closed human-in-the-loop HVAC control using the AI-enabled wearable sensor system confirms both the accuracy of the thermal comfort prediction and the energy-efficiency of this approach, demonstrating its potential as a new solution that improves the occupant's thermal comfort and provides building energy savings.


Sujet(s)
Techniques de biocapteur , Dispositifs électroniques portables , Humains , Température , Intelligence artificielle , Climatisation
2.
J Appl Stat ; 49(7): 1890-1899, 2022.
Article de Anglais | MEDLINE | ID: mdl-35707563

RÉSUMÉ

The recent controversy about the size of crowds at candlelight protests in Korea raises an interesting question regarding the methods used to estimate crowd size. Protest organizers tend to count all participants in the event from its start to finish, while the police usually report the crowd size at its peak. While several counting methods are available to estimate the size of a crowd at a given time, counting the total number of the participants at a protest is not straightforward. In this paper, we propose a new estimator to count the total number of participants that we call the size of a dynamic crowd. We assume that the arrival and departure times of the crowd are randomly observed and that the number of the attendees in the crowd at a specific time is estimable. We estimate the number of total attendees during the entire gathering based on the capture-recapture model. We also propose a bootstrap procedure to construct a confidence interval for the crowd size. We demonstrate the performance of the proposed method with simulation studies and the data from Korea's March for Science, a global event across the world on Earth Day, April 22, 2017.

3.
Exp Mol Med ; 54(2): 143-155, 2022 02.
Article de Anglais | MEDLINE | ID: mdl-35169224

RÉSUMÉ

Lipid mediators are crucial for the pathogenesis of rheumatoid arthritis (RA); however, global analyses have not been undertaken to systematically define the lipidome underlying the dynamics of disease evolution, activation, and resolution. Here, we performed untargeted lipidomics analysis of synovial fluid and serum from RA patients at different disease activities and clinical phases (preclinical phase to active phase to sustained remission). We found that the lipidome profile in RA joint fluid was severely perturbed and that this correlated with the extent of inflammation and severity of synovitis on ultrasonography. The serum lipidome profile of active RA, albeit less prominent than the synovial lipidome, was also distinguishable from that of RA in the sustained remission phase and from that of noninflammatory osteoarthritis. Of note, the serum lipidome profile at the preclinical phase of RA closely mimicked that of active RA. Specifically, alterations in a set of lysophosphatidylcholine, phosphatidylcholine, ether-linked phosphatidylethanolamine, and sphingomyelin subclasses correlated with RA activity, reflecting treatment responses to anti-rheumatic drugs when monitored serially. Collectively, these results suggest that analysis of lipidome profiles is useful for identifying biomarker candidates that predict the evolution of preclinical to definitive RA and could facilitate the assessment of disease activity and treatment outcomes.


Sujet(s)
Antirhumatismaux , Polyarthrite rhumatoïde , Synovite , Antirhumatismaux/usage thérapeutique , Polyarthrite rhumatoïde/traitement médicamenteux , Polyarthrite rhumatoïde/anatomopathologie , Humains , Lipidomique , Synovie , Synovite/traitement médicamenteux , Échographie/effets indésirables
4.
ACS Appl Mater Interfaces ; 8(41): 27730-27739, 2016 Oct 19.
Article de Anglais | MEDLINE | ID: mdl-27723306

RÉSUMÉ

Supportless Pt catalysts have several advantages over conventional carbon-supported Pt catalysts in that they are not susceptible to carbon corrosion. However, the need for high Pt loadings in membrane electrode assemblies (MEAs) to achieve state-of-the-art fuel cell performance has limited their application in proton exchange membrane fuel cells. Herein, we report a new approach to the design of a supportless Pt catalyst in terms of catalyst layer architecture, which is crucial for fuel cell performance as it affects water management and oxygen transport in the catalyst layers. Large Pt hollow spheres (PtHSs) 100 nm in size were designed and prepared using a carbon template method. Despite their large size, the unique structure of the PtHSs, which are composed of a thin-layered shell of Pt nanoparticles (ca. 7 nm thick), exhibited a high surface area comparable to that of commercial Pt black (PtB). The PtHS structure also exhibited twice the durability of PtB after 2000 potential cycles (0-1.3 V, 50 mV/s). A MEA fabricated with PtHSs showed significant improvement in fuel cell performance compared to PtB-based MEAs at high current densities (>800 mA/cm2). This was mainly due to the 2.7 times lower mass transport resistance in the PtHS-based catalyst layers compared to that in PtB, owing to the formation of macropores between the PtHSs and high porosity (90%) in the PtHS catalyst layers. The present study demonstrates a successful example of catalyst design in terms of catalyst layer architecture, which may be applied to a real fuel cell system.

5.
Small ; 12(38): 5347-5353, 2016 Oct.
Article de Anglais | MEDLINE | ID: mdl-27515995

RÉSUMÉ

Developing highly active and stable cathode catalysts is of pivotal importance for proton exchange membrane fuel cells (PEMFCs). While carbon-supported nanostructured Pt-based catalysts have so far been the most active cathode catalysts, their durability and single-cell performance are yet to be improved. Herein, self-supported mesostructured Pt-based bimetallic (Meso-PtM; M = Ni, Fe, Co, Cu) nanospheres containing an intermetallic phase are reported, which can combine the beneficial effects of transition metals (M), an intermetallic phase, a 3D interconnected framework, and a mesoporous structure. Meso-PtM nanospheres show enhanced oxygen reduction reaction (ORR) activity, compared to Pt black and Pt/C catalysts. Notably, Meso-PtNi containing an intermetallic phase exhibits ultrahigh stability, showing enhanced ORR activity even after 50 000 potential cycles, whereas Pt black and Pt/C undergo dramatic degradation. Importantly, Meso-PtNi with an intermetallic phase also demonstrated superior activity and durability when used in a PEMFC single-cell, with record-high initial mass and specific activities.

6.
J Immunol ; 195(5): 2472-82, 2015 Sep 01.
Article de Anglais | MEDLINE | ID: mdl-26216889

RÉSUMÉ

The development of an anti-influenza vaccine with the potential for cross-protection against seasonal drift variants as well as occasionally emerging reassortant viruses is essential. In this study, we successfully generated a novel anti-influenza vaccine system combining conserved matrix protein 2 (sM2) and stalk domain of hemagglutinin (HA2) fusion protein (sM2HA2) and poly-γ-glutamic acid (γ-PGA)-based vaccine adjuvant systems that can act as a mucoadhesive delivery vehicle of sM2HA2 as well as a robust strategy for the incorporation of hydrophobic immunostimulatory 3-O-desacyl-4'-monophosphoryl lipid A (MPL) and QS21. Intranasal coadministration of sM2HA2 and the combination adjuvant γ-PGA/MPL/QS21 (CA-PMQ) was able to induce a high degree of protective mucosal, systemic, and cell-mediated immune responses. The sM2HA2/CA-PMQ immunization was able to prevent disease symptoms, confering complete protection against lethal infection with divergent influenza subtypes (H5N1, H1N1, H5N2, H7N3, and H9N2) that lasted for at least 6 mo. Therefore, our data suggest that mucosal administration of sM2HA2 in combination with CA-PMQ could be a potent strategy for a broad cross-protective influenza vaccine, and CA-PMQ as a mucosal adjuvant could be used for effective mucosal vaccines.


Sujet(s)
Adjuvants immunologiques/composition chimique , Vaccins antigrippaux/composition chimique , Vaccins antigrippaux/immunologie , Polymères/composition chimique , Adjuvants immunologiques/administration et posologie , Animaux , Protection croisée/immunologie , Glycoprotéine hémagglutinine du virus influenza/composition chimique , Glycoprotéine hémagglutinine du virus influenza/immunologie , Interactions hôte-pathogène/immunologie , Système immunitaire/immunologie , Immunité cellulaire/immunologie , Immunité muqueuse/immunologie , Immunisation , Sous-type H1N1 du virus de la grippe A/immunologie , Sous-type H1N1 du virus de la grippe A/physiologie , Sous-type H5N1 du virus de la grippe A/immunologie , Sous-type H5N1 du virus de la grippe A/physiologie , Sous-type H5N2 du virus de la grippe A/immunologie , Sous-type H5N2 du virus de la grippe A/physiologie , Sous-type H7N3 du virus de la grippe A/immunologie , Sous-type H7N3 du virus de la grippe A/physiologie , Sous-type H9N2 du virus de la grippe A/immunologie , Sous-type H9N2 du virus de la grippe A/physiologie , Vaccins antigrippaux/administration et posologie , Souris de lignée BALB C , Infections à Orthomyxoviridae/immunologie , Infections à Orthomyxoviridae/prévention et contrôle , Infections à Orthomyxoviridae/virologie , Acide polyglutamique/analogues et dérivés , Acide polyglutamique/composition chimique , Acide polyglutamique/immunologie , Protéines de la matrice virale/composition chimique , Protéines de la matrice virale/immunologie
7.
Liver Transpl ; 10(6): 802-6, 2004 Jun.
Article de Anglais | MEDLINE | ID: mdl-15162476

RÉSUMÉ

We considered performing living donor liver transplantation (LDLT) in a larger-size recipient. When the recipient was large-sized, or when the donor liver was severely steatotic or had a right-to-left volume discrepancy. We devised dual living donor liver transplantation (DLDLT) to make up for graft size insufficiency and to secure the donor's safety. However, portal vein thrombosis (PVT) presented a challenge for DLDLT because of the need for intact right and left portal veins for the implantation of both liver grafts. Our 52-year-old male patient with hepatitis B cirrhosis had suffered from repeated esophageal and gastric variceal bleeding and underwent 2 trials of a transjugular intrahepatic portosystemic shunt (TIPS). He developed TIPS occlusion and PVT involving the area just above the spleno-mesenteric confluence to the right and left PV. Also, the right PV orifice was destructed and difficult to isolate because of severe periportal inflammation and neointima growth in the TIPS mesh. The patient's two sons were inadequate for donation because of right-to-left volume discrepancy. Therefore, DLDLT using 2 left lobes was necessary to compensate for graft-size insufficiency and to secure donor safety, and we substituted an intact umbilical portion of recipient's left PV for the destroyed right PV. The patient recovered well, and liver function has been normal for more than a year. In conclusion, the umbilical portion of recipient's left PV can be a useful vascular substitute for the reconstruction of a thrombosed main portal branch in DLDLT.


Sujet(s)
Transplantation hépatique , Donneur vivant , Veine porte/transplantation , Ombilic/vascularisation , Thrombose veineuse/chirurgie , Adulte , Hépatite B/complications , Humains , Imagerie tridimensionnelle , Cirrhose du foie/complications , Cirrhose du foie/chirurgie , Cirrhose du foie/virologie , Transplantation hépatique/méthodes , Mâle , Adulte d'âge moyen , Tomodensitométrie , Résultat thérapeutique , Thrombose veineuse/complications , Thrombose veineuse/imagerie diagnostique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE